Ibio Inc IBIO:NYSE American

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 03/28/24 EDT
4.01quote price arrow down-0.05 (-1.23%)
Volume
319,588
Close
4.06quote price arrow up+0.70 (+20.83%)
Volume
42,461,031
52 week range
1.02 - 49.80
Loading...
  • Open4.20
  • Day High4.98
  • Day Low3.66
  • Prev Close3.36
  • 52 Week High49.80
  • 52 Week High Date03/28/23
  • 52 Week Low1.02
  • 52 Week Low Date01/18/24

Key Stats

  • Market Cap14.146M
  • Shares Out3.48M
  • 10 Day Average Volume17.13M
  • Dividend-
  • Dividend Yield-
  • Beta-3.54
  • YTD % Change196.35

KEY STATS

  • Open4.20
  • Day High4.98
  • Day Low3.66
  • Prev Close3.36
  • 52 Week High49.80
  • 52 Week High Date03/28/23
  • 52 Week Low1.02
  • 52 Week Low Date01/18/24
  • Market Cap14.146M
  • Shares Out3.48M
  • 10 Day Average Volume17.13M
  • Dividend-
  • Dividend Yield-
  • Beta-3.54
  • YTD % Change196.35

RATIOS/PROFITABILITY

  • EPS (TTM)-21.91
  • P/E (TTM)-0.19
  • Fwd P/E (NTM)-2.91
  • EBITDA (TTM)-19.826M
  • ROE (TTM)-148.27%
  • Revenue (TTM)50,000.001
  • Gross Margin (TTM)75.41%
  • Net Margin (TTM)-41,546.00%
  • Debt To Equity (MRQ)146.44%

EVENTS

  • Earnings Date05/14/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Ibio Inc

 

Profile

MORE
iBio, Inc. is a preclinical stage biotechnology company that leverages artificial intelligence (AI) for the development of precision antibodies. The Company develops biopharmaceuticals using computational biology and 3D-modeling of subdominant and conformational epitopes, prospectively enabling the discovery of new antibody treatments for hard-to-target cancers and other diseases. Its StableHu technology is an AI-based tool designed to predict a library of antibodies with...
William Clark
Independent Chairman of the Board
Martin Brenner Ph.D.
Chief Executive Officer, Chief Scientific Officer
Felipe Duran
Chief Financial Officer
Address
8800 HSC Pkwy
Bryan, TX
77807
United States

Top Peers

SYMBOLLASTCHG%CHG
NDRA
ENDRA Life Sciences Inc
0.58-0.2403-29.2942%
GOVX
GeoVax Labs Inc
2.00+0.15+8.11%
ATHE
Alterity Therapeutics Ltd
2.07+0.05+2.48%
IMNN
Imunon Inc
1.64+0.24+17.14%
NEXI
Neximmune Inc
5.61+0.10+1.81%